Kemal Malik

Director, Acceleron Pharma.

Companies

Selecta Biosciences (United States)Board member Jul 3, 2024 to now¹
Acceleron PharmaBoard member Jan 3, 2020 to Nov 22, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Selecta Biosciences (United States) RNAC11,133 shares³$67.7K at $6.08Jan 2, 2026
Acceleron Pharma XLRN0 shares⁴Nov 19, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 2, 2026Granted 2,600 shares of Selecta Biosciences (United States)³
Jan 2, 2025Granted 2,600 shares of Selecta Biosciences (United States)⁵
Jul 1, 2024Granted 5,933 shares of Selecta Biosciences (United States)⁶
Nov 19, 2021U 1,622 shares of Acceleron Pharma⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSelecta Biosciences (United States), Board member
2
SEC EDGARAcceleron Pharma, Board member
3
SEC EDGARSelecta Biosciences (United States) shares after the filing of Jan 2, 2026
4
SEC EDGARAcceleron Pharma shares after the filing of Nov 19, 2021
5
SEC EDGARForm 4 filed Jan 6, 2025
6
SEC EDGARForm 4 filed Jul 3, 2024